Home News Wegovy and Zepbound Shortages Will Last Until Summer back to News
minute read
Shortages of the popular injected weight-loss medicines Wegovy (semaglutide) and Zepbound (tirzepatide) aren’t going to end any time soon, according to the U.S. Food and Drug Administration (FDA).
Topics: Press Coverage
12631 East 17th Avenue
8601
Aurora, CO 80045
303-724-1785
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
